Accelerated induction regimens of TNF-alpha inhibitors in patients with inflammatory bowel disease: a scoping review protocol

INTRODUCTION: Tumour necrosis factor (TNF)-alpha inhibitors are commonly used to treat inflammatory bowel disease (IBD). In patients with IBD who are unresponsive to their first induction dose, the implementation of an ‘accelerated’ induction dose schedule (doses more frequent than recommended in pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Amy, Natarajan, Sabrina, Hayes, Meghan, MacDonald, Erika, Shorr, Risa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829849/
https://www.ncbi.nlm.nih.gov/pubmed/29382683
http://dx.doi.org/10.1136/bmjopen-2017-019909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829849/
https://www.ncbi.nlm.nih.gov/pubmed/29382683
http://dx.doi.org/10.1136/bmjopen-2017-019909

Ejemplares similares